G
Note: This synopsis follows a Sources Sought notice that was released on November 10, 2015 under HHS-NIH-NCI-SBSS-ETSB-1004-38.
THIS IS A NOTICE OF INTENT, NOT A REQUEST FOR PROPOSAL. A SOLICITATION WILL BE ISSUED ON A LATER DATE.
Title: Inherited Bone Marrow Failure Syndrome Support Services Contract
Background:
The Division of Cancer Epidemiology and Genetics (DCEG’s) research focuses on discovering genetic and environmental determinants of cancer and identifying new approaches to cancer prevention. This project is for the re-competition of contract HHSN261201100018C with Westat, Inc., which was awarded on a competitive basis for a five - year period. The Government anticipates that one (1) contract will be awarded with a base period of one year and four one year option periods. The NAICS Code is 541990.The purpose of this contract will be to provide support services for the Inherited Bone Marrow Failure Syndromes (IBMFS) Program which involves large numbers of families in which there is proband with a cancer-prone IBMFS, and includes both family studies at the NIH Cancer Center and field studies of members of large families. The NCI is seeking capability statements from all eligible small businesses concerns in performing the tasks/duties herein.
The contractor will be required to perform the duties set forth in the attached draft Statement of Work.
Anticipated Period of Performance:
The anticipated period of performance, inclusive of options, is December 1, 2016 – November 30, 2021.
The RFP will be available electronically at a later date and may be accessed through the FedBizOps at www.fbo.gov. WE ENCOURAGE ALL RESPONSIBLE SOURCES, PARTICULARLY SMALL BUSINESSES, TO SUBMIT A PROPOSAL WHICH WILL BE CONSIDERED BY THE AGENCY. This notice does not commit the Government to award a contract. No collect calls will be accepted. No facsimile or email transmissions will be accepted. IT IS THE OFFERORS RESPONSIBILITY TO MONITOR THE ABOVE MENTIONED SITE FOR THE RELEASE OF THE SOLICITATION AND ANY AMENDMENTS.